官方服务：
资源简介：
Targeted capture ctDNA Library CRCQV42Run049-17 from patient PBC0001810, buffy coat sampleEGA dataset EGAD00001010770
应用场景：
创建时间：
2023-05-12
相关数据集
DataSheet_1_Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma.xlsx
Esophageal squamous cell carcinoma (ESCC) is lethal as tumors are rarely detected at an early stage and have a high recurrence rate. There are no particularly useful biomarkers for the prognostic pred
NIAID Data Ecosystem40
Table_6_Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.xlsx
IntroductionAnalyzing liquid biopsies for tumor-specific aberrations can facilitate detection of measurable residual disease (MRD) during treatment and at follow-up. In this study, we assessed the cli
NIAID Data Ecosystem30
DataSheet3_Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer.zip
Breast cancer (BC) is the most commonly diagnosed malignant tumor in women worldwide, and the leading cause of cancer death in the female population. The percentage of patients experiencing poor progn
NIAID Data Ecosystem10
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
This is multicentric, interventional, non farmacological and prospective study.
NIAID Data Ecosystem30
YAP/TAZ-dependent expression of lncRNAs [A549]
Body fluids from cancer patients are informative regarding disease conditions in tumor tissues. Thus, biomarkers detected by liquid biopsy can guide clinicians in designing personalized therapies and
NIAID Data Ecosystem10
